跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,850 条关于
“Fitch Ratings”
全部
2,850
临床试验
2,443
药物
15
机构
5
资讯
387
上个月
Moody's Upgrades Teva to Investment Grade, Marking Milestone in Pivot to Growth Strategy
上个月
H.R. 1 Medicaid Cuts Threaten Hospital Finances as Uninsured Rate Climbs Toward 16 Million More Americans
上个月
Analysts Maintain Buy Ratings on Vir Biotechnology Despite Widening Losses
上个月
Analysts Maintain Buy Ratings on Sino Biopharmaceutical with Strong Upside Potential
3个月前
Analyst Ratings Diverge on Healthcare Stocks as Moderna Faces Continued Pressure
3个月前
Jefferies Analysts Issue Mixed Ratings on Pharma Giants Novartis and Sanofi
去年
Ipsen Secures €500 Million Inaugural Rated Public Bond Following Investment Grade Ratings
上个月
Analysts Maintain Buy Ratings on Fresenius SE & Co. KGaA Amid Positive Insider Sentiment
去年
FDA Adds Pulmonary Aspiration Warning to GLP-1 Receptor Agonists
去年
Cytokinetics' CK-586 Advances in Phase 2 AMBER-HFpEF Trial, Bolstering Buy Ratings
第 1 页,共 39 页
上一页
下一页